ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,400, issued on July 29, was assigned to ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) (Leiden, Netherlands).
"Cathepsin inhibitors" was invented by Huib Ovaa (Leiden, Netherlands), Maria Wilhelmina Elisabeth Mons (Leiden, Netherlands) and Stan Van Boeckel (Leiden, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention."
The patent was filed on Oct. 10, 2023, under Application No. 18...